{"id":"W7065352997","doi":"","title":"Dabrafenib plus trametinib in patients with BRAFV600E-mutant low-grade and high-grade glioma (ROAR): a multicentre, open-label, single-arm, phase 2, basket trial","year":2022,"lang":"en","type":"article","venue":"Utrecht University Repository (Utrecht University)","topic":"Magnetic confinement fusion research","field":"Physics and Astronomy","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Dabrafenib; Trametinib; Glioma; Progressive disease; Radiation therapy; Phases of clinical research; Complete response; Response Evaluation Criteria in Solid Tumors; Chemotherapy","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002993289,0.0004666225,0.0006296975,0.001014731,0.001082211,0.0001665795,0.001333531,0.0001195861,0.007509125],"category_scores_gemma":[0.00001379345,0.0005414277,0.0001060959,0.00182779,0.0002950761,0.000326695,0.001716802,0.0007760024,0.000006638049],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005638076,"about_ca_system_score_gemma":0.0005667984,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005017873,"about_ca_topic_score_gemma":0.0002327742,"domain_scores_codex":[0.9960868,0.000846828,0.0003747494,0.001106598,0.0008398313,0.0007451318],"domain_scores_gemma":[0.99803,0.000320885,0.0003738161,0.0006779601,0.0001494977,0.0004478541],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.3773347,0.2060095,0.08933131,0.0004204084,0.003481149,0.01552085,0.009154974,0.0006707571,0.02362467,0.01962672,0.01693495,0.23789],"study_design_scores_gemma":[0.7327746,0.01077188,0.004126151,0.0002073867,0.000770504,0.00001990118,0.02048058,0.002675904,0.004893395,0.0000627215,0.2210052,0.002211795],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9569133,0.00001184521,0.0001202401,0.000364944,0.0003365023,0.002430478,0.0002562006,0.00008608859,0.03948039],"genre_scores_gemma":[0.972808,0.000004948231,0.0005663664,0.00002720841,0.00006749874,0.000005126033,0.0001946846,0.00003502831,0.02629112],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3554399,"threshold_uncertainty_score":0.9997037,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01659609138765078,"score_gpt":0.2232773724142677,"score_spread":0.2066812810266169,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}